Dual role of Ras and Rho proteins: At the cutting edge of life and death

Immunology and Cell Biology

Volumn 76, Issue 2, 1998, Pages 125-134

  Gómez, Javier ^a   Martínez A, Carlos ^a   González, Ana ^a   Rebollo, Angelita ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Adhesion; Apoptosis; Cell differentiation; Cell proliferation; Cytoskeleton; GTP binding proteins; Ras; Rho; Transformation

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; RAS PROTEIN;

APOPTOSIS; CELL DEATH; CELL DIFFERENTIATION; CELL DIVISION; CYTOSKELETON; HUMAN; NONHUMAN; PROTEIN DETERMINATION; PROTEIN PROTEIN INTERACTION; REVIEW;

APOPTOSIS; CELL ADHESION; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; CYTOSKELETON; GTP-BINDING PROTEINS; RAS PROTEINS; RHO FACTOR; SIGNAL TRANSDUCTION;

EID: 0031925742     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1711.1998.00723.x     Document Type: Review

References (141)

1. Wylli AH. The genetic regulation of apoptosis. Curr. Opin. Genet. Dev. 1995; 5: 97-104.
2. Arends MJ, Morris RG, Wyllie AH. Apoptosis is inversely related to necrosis and determines net growth in tumors bearing constitutively expressed myc, ras and HPV oncogenes. Am. J. Pathol. 1990; 136: 593-608.
3. Wyllie AH, Arends MJ, Morris RG, Walker SW, Evan G. The apoptosis endonuclease and its regulation. Semin. Immunol. 1992; 4: 389-97.
4. Nagata S, Goldstein P. The Fas death factor. Science 1995; 267: 1449-56.
5. Korsmeyer SJ. Regulators of cell death. Trends Genet. 1995; 11: 101-5.
6. Zetterberg A, Larsson O, Wiman KG. What is the restriction point? Curr. Opin. Cell Biol. 1995; 7: 835-42.
7. Graña X, Reddy EP. Cell cycle control in mammalian cells: Role of cyclins, cyclin-dependent kinases, growth suppressor genes and cyclin-dependent kinase inhibitors. Oncogene 1995; 11: 211-17.
8. Hall A. Ras-related proteins. Curr. Opin. Cell Biol. 1993; 376: 265-8.
9. Chavrier P, Gorvel JP, Bertoglio J. An immunologist's look at the Rho and Rab GTP-binding proteins. Immunol. Today 1993; 14: 440-4.
10. Ridley AJ. Rho-related proteins: Actin cytoskeleton and cell cycle. Curr. Opin. Genet. Dev. 1995; 5: 24-30.
11. Boguski MS, McCormick F. Proteins regulating Ras and its relatives. Nature 1993; 366: 643-54.
12. Habets GGM, Scholtes EH, Zuydgeest D et al. Identification of an invasion-inducing gene, Tiam-1, that encodes a protein with homology to GTP-GDP exchangers for Rho-like proteins. Cell 1994; 77: 537-49.
13. Bourne HR, Sanders DA, McCormick F. The GTPase superfamily: A conserved switch for diverse cell functions. Nature 1990; 348: 125-32.
14. Bollagand G, McCormick F. Regulators and effectors of Ras proteins. Annu. Rev. Cell Biol. 1991; 7: 601-33.
15. Feig LA. The many roads that lead to Ras. Science 1993; 260: 767-8.
16. Bowtell D, Fu P, Simon M, Senior P. Identification of murine homologues of the Drosophila son of sevenless gene: Potential activator of Ras. Proc. Natl Acad. Sci. USA 1992; 89: 6511-15.
17. Martegani E, Vanoni M, Zippel R et al. Cloning by functional complementation of a mouse cDNA encoding a homologue of CDC25, a S. cerevisiae Ras activator. EMBO J. 1992; 11: 2151-7.
18. Glomset JA, Farnsworth CC. Role of protein modification reactions in programming interactions between Ras-related GTPases and cell membranes. Annu. Rev. Cell Biol. 1994; 10: 181-205.
19. Egan SE, Giddings BW, Brooks MW, Buday L, Sizeland AM, Weinberg RA. The pathway to signal achievement. Nature 1993; 363: 45-51.
20. Reis Y, Stradley SJ, Gierasch LM, Brown MS, Goldstein JL. Sequence requirement for peptide recognition by rat brain p21ras protein farnesyltransferase. Proc. Natl Acad. Sci. USA 1991; 88: 732-6.
21. Moodie SA, Willumsen BM, Weber MJ, Wolfman A. Complexes of Ras GTP with Raf1 and mitogen-activated protein kinase. Science 1993; 260: 1658-61.
22. Warne PH, Viciana PR, Downward J. Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro. Nature 1993; 64: 352-5.
23. Zang X, Settleman J, Kyriakis JM et al. Normal and oncogenic p21ras protein bind to the amino terminal regulatory domain of Raf. Nature 1993; 364: 308-13.
24. Marshall CJ. Specificity of receptor tyrosine kinase signaling: Transient vs. sustained extracellular signal-regulated kinase activation. Cell 1995; 80: 179-85.
25. Deut P, Haser W, Haystead TAJ, Vincent LA, Roberts TM, Sturgill TW. Activation of mitogen-activated protein kinase kinase by v-Raf in NIH 3T3 cells and in vitro. Science 1992; 257: 1404-7.
26. Lange-Carter CA, Pleiman CM, Gardner AM, Blumer KJ, Johnson GL. Ras-dependent growth factor regulation of MEK kinase in PC12 cells. Science 1993; 260: 315-19.
27. Zheng CF, Guan KL. Activation of MEK family kinases requires phosphorylation of two conserved ser/thr residues. EMBO J. 1994; 13: 1123-31.
28. Kyriakis JM, Banerjee P, Nikolakaki E et al. Raf-1 activates MAP kinase-kinase. Nature 1994; 369: 156-60.
29. Hill CS, Treisman R. Transcriptional regulation by extracellular signals: Mechanisms and specificity. Cell 1995; 80: 199-211.
30. Ihle JN, Witthuhn BA, Quelle FW, Yamamoto K, SiIvennoinen O. Signaling through the hematopoietic cytokine receptors. Annu. Rev. Immunol. 1995; 13: 369-98.
31. Quelle FW, Sato N, Witthuhn BA et al. Jak2 associates with the βc chain of the receptor for GM-CSF, and its activation requires the membrane-proximal region. Mol. Cell. Biol. 1994; 14: 4335-41.
32. Rodriguez-Viciana P, Warne PH, Dhand R. Phosphatidylinositol 3 kinase as a direct target of Ras. Nature 1994; 370: 527-32.
33. Diaz-Meco MT, Lozano J, Municio M, Moscat J. Evidence for the in vitro and in vivo interaction of Ras with protein kinase C zeta. J. Biol. Chem. 1994; 269: 31 706-10.
34. Shimizu K, Kuroda S, Matsuda S. Synergistic activation by Ras and 14-3-3 protein of a MAPKKK named Ras-dependent extracellular signal-regulated kinase kinase stimulator. J. Biol. Chem. 1994; 269: 22 917-20.
35. Hoofer F, Fields S, Schneider C, Martin GS. Activated Ras interacts with the RaI GDS. Proc. Natl Acad. Sci. USA 1994; 91: 11 089-93.
36. Han L, Colicelli J. A human protein selected for interference with Ras function interacts directly with Ras and competes with Raf1. Mol. Cell. Biol. 1995; 15: 1318-23.
37. Russel M, Lange CC, Johnson GL. Direct interaction between Ras and the kinase domain of mitogen activated protein kinase kinase kinase (MEKK1). J. Biol. Chem. 1995; 270: 11 757-60.
38. Therrien M, Chang HC, Solomon NM, Karin FD, Wassarman DA, Rubin GM. KSR, a novel protein kinase required for Ras signal transduction. Cell 1995; 83: 879-88.
39. Zhang Y, Yao B, Delikat S et al. Kinase suppressor of Ras is ceramide-activated protein kinase. Cell 1997; 89: 63-72.
40. Xing H, Kornfeld K, Muslin AJ. The protein kinase KSR interacts with 14-3-3 protein and Raf. Curr. Biol. 1997; 7: 294-300.
41. Derijard B, Hibi M, Wu IH et al. JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-jun activation domain. Cell 1994; 76: 1025-37.
42. Su B, Jacinto E, Hibi M, Kallunki T, Karin M, Ben-Neriah Y. JNK is involved in signal integration during costimulation of T lymphocytes. Cell 1994; 77: 727-36.
43. Gómez J, Martinez-AC, Fernández B, García A, Rebollo A. Critical role of Ras in the proliferation and prevention of apoptosis mediated by IL-2. J. Immunol. 1996; 157: 2272-81.
44. Gómez J, Martínez-AC, Rebollo A. Ras-mediated cell proliferation and cell death: Some clues from the IL-2 receptor system. Apoptosis 1996; 1: 175-82.
45. Gómez J, Martínez-AC, Fernández B, García A, Rebollo A. Ras activation leads to cell proliferation or apoptotic cell death upon IL-2 stimulation or lymphokine deprivation, respectively. Eur. J. Immunol. 1997; 27: 1610-18.
46. Gómez J, García A, Borlado L et al. 1L-2 signaling controls actin organization through Rho-like protein family, phosphatidylinositol 3 kinase and protein kinase Cζ. J. Immunol. 1997; 158: 1516-22.
47. Maher J, Baker D, Dibb N, Robert I. Mutant Ras promotes haemopoietic cell proliferation or differentiation in a cell-specific manner. Leukemia 1996; 10: 83-90.
48. Burbelo PD, Miyamoto A, Utani S et al. p190-B, a new member of the Rho GAP family, and Rho are induced to cluster after integrin cross-linking J. Biol. Chem. 1995; 270: 30 919-26.
49. Tribioli C, Droetto S, Bione S et al. An X chromosome-linked gene encoding a protein with characteristics of a RhoGAP predominantly expressed in hematopoietic cells. Proc. Natl Acad. Sci. USA 1996; 93: 695-9.
50. Chuang TH, Xu X, Kaartinen V, Heisterkamp N, Groffen J, Bokoch GM. Abr and Bcr are multifunctional regulators of the Rho-GTP binding protein family. Proc. Natl Acad. Sci. USA 1995; 92: 10 282-6.
51. Ridley AJ, Hall A. The small GTP-binding protein Rho regulates the assembly of focal adhesions and actin stress libers in response to growth factors. Cell 1992; 70: 389-99.
52. Lang P, Guizani N, Vitte-Mony I et al. ADP-ribosylation of the Ras related GTP-binding protein RhoA inhibits lymphocyte-mediated cytotoxicity. J. Biol. Chem. 1992; 267: 11 677-80.
53. Sugai M, Chen C, Wu HC. Staphylococcal ADP-ribosyl transferase-sensitive small G protein is involved in brefeldrin A action. J. Biol. Chem. 1992; 267: 21 297-9.
54. Esteve P, Peso L, Lacal JC. Induction of apoptosis by Rho in NIH3T3 cells requires two complementary signals: Ceramides function as a progression factor for apoptosis. Oncogene 1995; 11: 2657-65.
55. Jimenez B, Arend M, Esteve P et al. Induction of apoptosis in NIH3T3 cells after serum deprivation by overexpression of Rho-p21, a GTPase protein of the Ras superfamily. Oncogene 1995; 10: 811-16.
56. Zang J, King WG, Dillon S, Hall A, Feig L, Rittenhouse SE. Activation of platelet phosphatidylinositol 3 kinase requires the small GTP-binding protein Rho. J. Biol. Chem. 1993; 268: 22 251-4.
57. Schmidt M, Rumenapp U, Bienek C, Keller J, Eichel-Streiber C, Jakobs KH. Inhibition of receptor signaling to phospholypase D by C. difficile toxin B: Role of Rho proteins. J. Biol. Chem. 1996; 271: 2422-6.
58. Ridley AJ, Hall A. Signal transduction pathways regulating Rho-mediated stress fiber formation: Requirement for a tyrosine kinase. EMBO J. 1994; 13: 2600-10.
59. Amano M, Mukai H, Ono Y et al. Phosphorylation and activation of myosin by Rho-associated kinase. Science 1996; 271: 648-50.
60. Watanabe G, Saito Y, Madaule P et al. Protein kinase N (PKN) and PKN-related protein rophilin as target of small GTPase Rho. Science 1996; 271: 645-8.
61. Leung T, Manser E, Tan L, Lim L. A novel serine-threonin kinase binding the Ras-related RhoA GTPase which translocates the kinase to peripheral membrane. J Biol. Chem. 1995; 270: 29 051-4.
62. Amano M, Chichara K, Kimura K et al. Identification of a putative target for Rho as the serine-threonine kinase protein kinase N. Science 1997; 275: 1308-11.
63. Dobrowolski S, Harte M, Staccy DW. Cellular Ras activity is required for passage through multiple points of the G0-G1 phase in BALB-c 3T3 cells. Mol. Cell. Biol. 1994; 14: 5441-9.
64. Pan BT, Chen CT, Lin SM. Oncogenic Ras blocks cell cycle progression and inhibits p34cdc2 kinase in activated Xenopus egg extracts. J. Biol. Chem. 1994; 269: 5968-75.
65. Lovec H, Sewing A, Lucibello FC, Muller R, Moroy T. Oncogenic activity cyclin D1 revealed through cooperation with H-ras, link between cell cycle control and malignant transformation. Oncogene 1994; 9: 323-6.
66. Liu J, Chao J, Jiang MC, Yu S, Yong-Yung J, Yang-Yen H. Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH 3T3 cells. Mol. Cell. Biol. 1995; 15: 3654-63.
67. Albanese C, Johnson J, Watanabe G et al. Transforming p21 ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J. Biol. Chem. 1995; 270: 23 589-97.
68. Arber N, Sutter T, Miyake M et al. Increased expression of cyclin D1 and the Rb tumor suppressor gene in c-K-ras transformed rat enterocytes. Oncogene 1996; 12: 1903-8.
69. Peeper DS, Upton TM, Ladha MH et al. Ras signaling linked to the cell cycle machinery by the retinoblastoma protein. Nature 1997; 386: 177-81.
70. Aktas H, Cai H, Cooper GM. Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the cdk inhibitor p27 KIP1. Mol. Cell. Biol. 1997; 17: 3850-7.
71. Leone G, DeGregori J, Sears R, Jakoi L, Nevins JR. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. Nature 1997; 387: 422-6.
72. Galaktionov K, Chen X, Beach D. Cdc25 cell-cycle phosphatase as a target of c-Myc. Nature 1996; 382: 511-17.
73. Lloyd AC, Obermuller F, Staddon S, Barth CF, McMahon M, Land H. Cooperating oncogenes converge to regulate cyclin cdk complexes. Genes Dev. 1997; 11: 663-77.
74. Serrano M, Lian AW, McCurrach ME, Beach D, Lowe SW. Oncogenic Ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997; 88: 593-602.
75. Downward J. Cell cycle: Routine role for Ras. Curr. Biol. 1997; 7: R258-60.
76. Galaktionov K, Jessus C, Beach D. Specific activation of cdc25 tyrosin phosphatase by B-type cyclins: Evidence for multiple roles of mitotic cyclins. Genes Dev. 1995; 9: 1046-58.
77. Taylor SJ, Shalloway D. Cell cycle-dependent activation of Ras. Curr. Biol. 1997; 6: 1621-7.
78. Quilliam LA, Kato K, Rabun KM et al. Identification of residues critical for Ras N17 growth-inhibitory phenotype and for Ras interaction with guanine nucleotide exchange factors. Mol. Cell. Biol. 1994; 14: 1113-21.
79. Chen SY, Huff SY, Lai C, Der CJ, Powers S. Ras 15A protein shares highly similar dominant-negative biological properties with Ras 17N and forms a stable guanine-nucleotide resistant complex with CDC25 exchange factor. Oncogene 1994; 9: 2691-8.
80. Irani K, Herzlinger S, Finkel T. Ras proteins regulate multiple mitogenic pathways in A10 vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 1994; 202: 1252-8.
81. Szeberenyi J, Cai H, Cooper GM. Effect of a dominant inhibitory Ha-ras mutation on neuronal differentiation of PC12 cells. Mol. Cell. Biol. 1990; 10: 5324-32.
82. Downward J, Graves JD, Warne PH, Rayter S, Cantrell DA. Stimulation of p21 ras upon T cell activation. Nature 1990; 346: 719-23.
83. Graves JD, Downward J, Izquierdo M, Rayter S, Warne PH, Cantrell DA. The growth factor IL-2 activates p21ras proteins in normal human T lymphocytes. J. Immunol. 1992; 148: 2417-22.
84. Duronio V, Welham MJ, Abraham S, Dryden P, Schrader JW. p21 ras activation via hemopoietic receptors and c-kit requires tyrosine kinase activity but not tyrosine phosphorylation of p21ras GTPase-activating protein. Proc. Natl Acad. Sci. USA 1991; 89: 1587-91.
85. Pendergast GC, Khosravi-Far R, Solski PA, Kurzawa H, Lebowitz PF, Der CJ. Critical role of rho in cell transformation by oncogenic ras. Oncogene 1995; 10: 2289-96.
86. Qiu RG, Chen JG, Kim D, McCormick F, Symons M. An essential role for Rac in Ras transformation. Nature 1995a; 374: 457-9.
87. Qiu RG, Chen JG, McCormick F, Symons M. A role for Rho in Ras transformation. Proc. Natl Acad. Sci. USA 1995; 92: 11 781-5.
88. Clark EA, Hynes R. Ras activation is necessary for integrin-mediated activation of extracellular signal-regulated kinase 2 and cytosolic phospholipase A2 but not for cytoskeletal organization J. Biol. Chem. 1996; 271: 14 814-18.
89. Chen CY, Faller DV. Direction of p21 generated signals toward cell growth or apoptosis is determined by protein kinase C and Bcl-2. Oncogene 1995: 11: 1487-98.
90. Kinoshita T, Yokota T, Arai K, Miyajima A. Regulation of Bcl-2 expression by oncogenic Ras protein in hematopoietic cells. Oncogene 1995; 10: 2207-12.
91. Rodriguez-Viciana P, Warne PH, Khwaja A et al. Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell 1997; 89: 457-67.
92. Khwaja A, Rodriguez-Viciana P, Wennstrom S, Warne PH, Downward J. Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J. 1997; 16: 2783-93.
93. Fishkind DJ, Wang YI. Orientation and three-dimensional organization of actin filaments in dividing cultured cells. J. Cell Biol. 1994; 123: 837-48.
94. Juliano RL, Haskill S. Integrin-mediated activation of MAP or MEK kinases is independent of Ras. J. Cell Biol. 1993; 120: 577-85.
95. Nobes CD, Hall A, Rho, Rac and CDC42 GTPase regulate the assembly of multimolecular formed complexes. Cell 1995; 81: 53-62.
96. Weeds A, Maciver A. F-actin capping proteins. Curr. Opin. Biol. 1993; 5: 63-9.
97. Nobes CD, Hawkins P, Stephens L, Hall A. Activation of the small GTP-binding proteins rho and rac by growth factor receptors J. Cell Sci. 1995; 108: 225-33.
98. Moolenaar WH. c-AMP abrogates the p21MAP kinase pathway in fibroblasts. Trends Cell Biol. 1994; 4: 213-19.
99. Chong LD, Traynor-Kaplan A, Bokoch GM. Schwartz MA. The small GTP-binding protein Rho regulates a phosphatidylinositol-4-phosphate 5 kinase in mammalian cells. Cell 1994; 79: 507-13.
100. Malcolm KC, Ross AH, Qui RG, Symons M, Exton JH. Activation of the rat liver PLD by the small GTP-binding protein RhoA. J. Biol. Chem. 1994; 269: 25 951-4.
101. Schwartz MA, Toksoz D, Khosravi-Far R. Transformation by Rho exchange factor oncogenes is mediated by activation of an integrin-dependent pathway. EMBO J. 1996; 15; 6525-30.
102. Whitehead I, Kirk H, Kay R. Expression cloning of oncogenes by retroviral transfer of cDNA libraries. Mol. Cell. Biol. 1995; 15: 704-10.
103. Zeng Y, Olson MF, Hall A, Cerione RA, Toksoz D. Direct involvement of the small GTP-binding protein Rho in Ibc oncogene function. J. Biol. Chem. 1995; 270: 9031-4.
104. Tapon N, Hall A, Rho, Rac and Cdc42 GTPases regulate the organization of the actin cytoskeleton. Curr. Opin. Cell Biol. 1997; 9: 86-92.
105. Hill CS, Wynne J, Treistnan R. The Rho family GTPases RhoA, Rac1 and CDC42Hs regulated transcriptional activation by SRF. Cell 1995; 81: 1159-70.
106. Teramoto H, Crespo P, Coso OA, Igishi T, Xu N, Gutkind JS. The small GTP-binding protein rho activates c-Jun N-terminal kinases/stress-activated protein kinases in human kidney 293T cells: Evidence for a Pak-independent signaling pathway. J. Biol. Chem. 1996; 271: 25 713-34.
107. Osada S, Izawa M, Koyama T, Hirai S, Ohno S. A domain containing the Cdc42/Rac interactive binding region of p65 Pak inhibits transcriptional activation and cell transformation mediated by the Ras-Rac pathway. FEBS Lett. 1997; 404: 227-33.
108. Tang Y, Chen Z, Ambrose D et al. Kinase-deficient Pak1 mutants inhibit Ras transformation of Rat-1 fibroblast. Mol. Cell. Biol. 1997; 17: 4454-64.
109. Perona R, Esteve P, Jimenez B, Ballestro RP, Lacal JC. Tumorigenic activity of rho genes from A. californica. Oncogene 1993; 8: 1285-92.
110. Moorman JP, Bobak DA, Hahn CS. Inactivation of the small GTP binding protein Rho induces multinucleate cell formation and apoptosis in murine T lymphoma EL4. J. Immunol. 1996; 156: 4146-53.
111. Dubrez L, Goldwasser F, Genne P, Pommier Y, Solary E. The role of cell cycle regulation and apoptosis triggering in determining the sensitivity of leukemic cells to topoisomerase I and II inhibitors. Leukemia 1994; 9: 1013-18.
112. Laudanna C, Campbell JJ, Butcher EC. Role of Rho in chemoattractan-activated leukocyte adhesion through integrins. Science 1996; 271: 981-3.
113. Machesky LM, Hall A. Role of actin polymerization and adhesion to extracellular matrix in rac- and rho-induced cytoskeletal reorganization. J. Cell Biol. 1997; 138: 913-26.
114. Gulbins E, Bissonnette R, Mahbouhi A. Fas-induced apoptosis is mediated via ceramide-initiated Ras signaling pathway. Immunity 1995; 2: 341-51.
115. Wilson DJ, Fortner KA, Lynch DH. JNK, but not MAPK, activation is associated with Fas-mediated apoptosis in human T cells. Eur. J. Immunol. 1996; 26: 989-94.
116. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995; 270: 1326-31.
117. Ferrari G, Greene LA. Proliferative inhibition by dominant negative Ras rescues naive and neuronally differentiated PC 12 cells from apoptotic death. EMBO J. 1994; 13: 5922-8.
118. Henkemeyer M, Rossi DJ, Holmyard DP. Vascular system defects and neuronal apoptosis in mice lacking ras GTPase-activating protein. Nature 1995; 377: 695-701.
119. Wang HG, Millan JA, Cox AD. R-Ras promotes apoptosis caused by growth factor deprivation via a Bcl-2 suppressible mechanism. J. Cell Biol. 1995; 129: 1103-14.
120. Fernandez A, Fosdick LJ, Marin MC. Differential regulation of endogenous endonuclease activation in isolated murine fibroblast nuclei by ras and bcl-2. Oncogene 1995; 10: 769-74.
121. Di Jeso B, Ulianich L, Racioppi L. Serum withdrawal induces apoptotic cell death in Ki-ras transformed but not in normal differentiated thyroid cells. Biochem. Biophys. Res. Commun. 1995; 214: 819-24.
122. Tanaka N, Ishihara M, Kitagawa M. Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell 1994; 77: 829-39.
123. Fernandez A, Marin MC, McDonnell T, Ananthaswamy HN. Differential sensitivity of normal and Ha-ras transformed C3H mouse embryo fibroblasts to tumor necrosis factor: Induction of bcl-2, c-myc and manganese superoxide dismutase in resistant cells. Oncogene 1994; 9: 2009-17.
124. Chen CY, Faller DV. Phosphorylation of Bcl-2 protein and association with p21ras in ras-induced apoptosis J. Biol. Chem. 1996; 271: 2376-9.
125. Troppmair J, Rapp UR. Apoptosis regulation by Raf, Bcl-2 and R-Ras. Recent Results Cancer Res. 1997; 143: 245-9.
126. Spaargaren M, Martin GA, McCormick F, Fernandez-Sarabia MJ, Bischoff JR. The Ras related protein R-Ras interacts directly with Raf-1 in a GTP-dependent manner. Biochem. J. 1994; 300: 303-7.
127. Evan GI, Brown L, Whyte M, Harrington E. Apoptosis and the cell cycle. Curr. Opin. Cell Biol. 1995; 7: 825-34.
128. Fernandez S, Bischoff JR. Bcl-2 associates with the ras-related protein R-ras p23. Nature 1993; 366: 274-5.
129. Kauffmann-Zeh A, Rodriguez-Viciana P, Ulrich E et al. Suppression of c-myc-induced apoptosis by Ras signalling through PI3 K and PKB. Nature 1997; 385: 544-8.
130. Henning SW, Galandrini R, Hall A, Cantrell DA. The GTPase Rho has a critical regulatory role in thymus development. EMBO J. 1997; 16: 2397-407.
131. Gómez J, Martínez-A C, Giry M, García A. Rebollo A. Rho prevents apoptosis through Bcl-2 expression: Implications for IL-2 receptor signal transduction. Eur. J. Immunol. 1997; 27: 2793-9.
132. Minami Y, Nakagawa Y, Kawahara A. Protein tyrosine kinase Syk is associated with and activated by the IL-2R; Possible link with the c-myc induction pathway. Immunity 1995; 2: 89-100.
133. Miyazaki T, Liu ZJ, Kawahara A. Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc and lck cooperate in hematopoietic cell proliferation. Cell 1995; 81: 223-31.
134. Rebollo A, Gómez J, Martinez-AC. Lessons from immunological, biochemical and molecular pathways of the activation mediated by IL-2 and IL-4. Adv. Immumol. 1996; 63: 127-96.
135. Maslinski W, Remillard B, Tsudo M, Strom TB. IL-2 induces tyrosine kinase-dependent translocation of active Raf-1 from the IL-2 receptor into the cytosol. J. Biol. Chem. 1992; 267: 15 281-4.
136. Turner BC, Tonks NK, Rapp UR, Reed JC. IL-2 regulates Raf-1 kinase activity through a tyrosine phosphorylation-dependent mechanism in a T cell line. Proc. Natl Acad. Sci. USA 1993; 90: 5544-8.
137. Riedel D, Brennschidt U, Kiehntopf M, Brach M, Hermann F. The mitogenic response of T cells to IL-2 requires Raf-1. Eur. J. Immunol. 1993; 23: 3146-50.
138. Minami Y, Oishi I, Liu ZJ, Nakagawa S, Miyazaki T, Taniguchi T. Signal transduction mediated by the reconstituted IL-2 receptor: Evidence for a cell type-specific function of IL-2R beta chain. J. Immunol. 1994; 152: 5680-90.
139. Taieb J, Blanchard DA, Auffredou MT, Chaouchi N, Vazquez A. In vivo association between p56lck and MAP kinase during IL-2 mediated lymphocyte proliferation. J. Immunol. 1995; 155: 5623-30.
140. Kelly K, Siebenlist U. Immediate-early genes induced by antigen receptor stimulation. Curr. Opin. Immunol. 1995; 7: 327-32.
141. Grumont RJ, Rasko JE, Strasser A, Gerondakis S. Activation of the MAPK pathway induces transcription of the PAC-1 phosphatase gene. Mol. Cell. Biol. 1996; 16: 2913-21.